 ICL Appoints Dr. Eric McIntush As New CEOBy: ICL, Inc. 
Dr Eric Mcintush Ceo "We are thrilled to welcome Dr. Eric McIntush as our new CEO," said John G. Leslie, Chairperson of Immunology Consultants Laboratory. "Dr. McIntush's extensive expertise in both the scientific and business aspects of the antibody market make him the ideal leader for this next phase of our growth. His vision and leadership will be pivotal in expanding our research capabilities and ensuring that we continue to provide top-tier products for our customers." Dr. McIntush brings a wealth of experience in the antibody industry, having previously held senior leadership roles at Bethyl Laboratories where he led groundbreaking initiatives in product development. His deep understanding of the antibody market, paired with a proven track record in strategic growth and operational excellence, will enable Immunology Consultants Laboratory to build upon its strong foundation and propel the company toward new heights. "I am honored to join Immunology Consultants Laboratory at such an exciting time," said Dr. McIntush. "The company has a remarkable history of advancing immunology research and providing critical diagnostic solutions. I look forward to working alongside the team to further our mission and drive innovation that will positively impact both the healthcare industry and the patients we serve." To learn more about ICL and our products visit our website: Antibodies, Elisa Kits and Life Science Reagents | ICL Lab Photo: https://www.prlog.org/ End
|
Account Phone Number